-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/c-diff-infections_executive.pdf
December 01, 2011 - Layout 1
Introduction
Clostridium difficile infection (CDI) is a
serious healthcare-associated infection and
a growing health care problem. C. difficile
is a Gram-positive, spore-forming,
anaerobic bacterium that, when ingested,
can cause CDI if it is a toxigenic strain.
CDI symptoms include varying levels of
diarrh…
-
effectivehealthcare.ahrq.gov/sites/default/files/Masks-appendix-table-b-1-surveillance-report.xlsx
April 09, 2020 - B-1. RCTs Mask Use
Archived: This living report is not being updated. Findings may be used for research purposes, but should not be considered current.
Appendix Table B-1. Randomized controlled trials of mask use
Author
Registry # Publication Year Title Date Retrieved Source Link/URL Study Design Objectives Study Da…
-
effectivehealthcare.ahrq.gov/sites/default/files/masks-surveillance-2-appendix-table-a-1.xlsx
April 09, 2020 - B-1. RCTs Mask Use
Archived: This living report is not being updated. Findings may be used for research purposes, but should not be considered current.
Appendix Table A-1. Randomized controlled trials of mask use
Author
Registry # Publication Year Title Date Retrieved Source Link/URL Study Design Objectives Study Da…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/glaucoma-treatment_surveillance.pdf
January 01, 2013 - CER #60:
Treatment for Glaucoma: Comparative Effectiveness
Original release date:
April, 2012
Surveillance Report:
May, 2013
Key Findings:
- A large number of relatively small new studies were
identified that compared the effectiveness and safety of
existing treatments but none sufficiently challenge…
-
effectivehealthcare.ahrq.gov/sites/default/files/masks-appendix-table-b-1-version-2.xlsx
April 09, 2020 - B-1. RCTs Mask Use
Archived: This living report is not being updated. Findings may be used for research purposes, but should not be considered current.
Appendix Table B-1. Randomized controlled trials of mask use
Author
Registry # Publication Year Title Date Retrieved Source Link/URL Study Design Objectives Study Da…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/masks-appendix-table-b-1-version-1.xlsx
April 09, 2020 - Appendix Table B-1. RCTs of Masks
B-1. RCTs Mask Use
Archived: This living report is not being updated. Findings may be used for research purposes, but should not be considered current.
Appendix Table B-1. Randomized controlled trials of mask use
Author
Registry # Publication Year Title Date Retrieved Source Link/U…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/rapid-review-no-touch-modalities.pdf
May 01, 2022 - Rapid Evidence Product: No-Touch Modalities for Disinfecting Patient Rooms in Acute Care Settings
Rapid Evidence Product
October 2, 2020
No-Touch Modalities for Disinfecting
Patient Rooms in Acute Care Settings
Background and Purpose
Purpose of Review
To rapidly identify evidence assessing the effect of no-to…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/preterm-birth-terbutaline-pump_executive.pdf
September 01, 2011 - Layout 1
Background
Preterm birth is defined as delivery before
the completion of the 37th week of
gestation, and it affects 13 percent of live
births in the United States.1 According to
the 2010 National Vital Statistics report,
there were 542,893 preterm births in the
United States in 2006.2 Rates of preterm
birth…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/preterm-birth-terbutaline-pump_surveillance.pdf
January 30, 2013 - Source: www.effectivehealthcare.ahrq.gov
Published online: January 30, 2013
i
CER # 35:
Comparative Effectiveness of Terbutaline Pump for the Prevention of
Preterm Birth
Original release date:
September, 2011
Surveillance Report (1st Assessment/cycle 1):
May, 2012
Surveillance Report (2nd…
-
effectivehealthcare.ahrq.gov/health-topics/hearing-problems-children
November 18, 2015 - Tympanostomy Tubes
Research Protocol
Archived
November 18, 2015
Otitis Media With Effusion: Comparative Effectiveness of Treatments
Research Protocol
Archived
March 20, 2012
Evaluation and Treatment of Tinnitus: Comparative Effectiveness
Systematic Review
Archived…
-
effectivehealthcare.ahrq.gov/health-topics/genetic-counseling/
-
effectivehealthcare.ahrq.gov/health-topics/alzheimers-caregivers
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/primary-healthcare-spending-draft-tech-brief-appendix-g.xlsx
June 01, 2023 - About
Comparison of Primary Care Definition Code Sets
This workbook contains crosswalks of the codes states use to define, measure and report on primary care for the following code types: HCPCS / CPT, Place of Service, and Taxonomy. Using a combination of these code types, states are able to determine, for the purpo…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/asthma-immunotherapy-2011_research.pdf
January 01, 2011 - Methods Research Report
Development of Quality Criteria To Evaluate
Nontherapeutic Studies of Incidence, Prevalence, or
Risk Factors of Chronic Diseases: Pilot Study of New
Checklists
This report is based on research conducted by the Minnesota Evidence-based Practice Center
und…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-218-osteoporosis-fracture-prevention-evidence-summary.pdf
April 01, 2019 - CER 218 Evidence Summary: Long-Term Drug Therapy and Drug Holidays for Osteoporosis Fracture Prevention: A Systematic Review
Purpose of Review
To summarize the effects of long-term osteoporosis
drug treatment and of osteoporosis drug treatment
discontinuation and holidays.
Key Messages
• Evidence on the effects …
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/rfviia.pptx
May 01, 2010 - Refining Key Questions: Interactive Case Study Quiz
Comparative Effectiveness of Recombinant Factor VIIa for Off-Label Uses vs. Usual Care in the Hospital Setting
Prepared for:
Agency for Healthcare Research and Quality (AHRQ)
www.ahrq.gov
Comparative Effectiveness of Recombinant Factor VIIa for Off-Label Uses vs.…
-
effectivehealthcare.ahrq.gov/sites/default/files/rfviia.pptx
May 01, 2010 - Refining Key Questions: Interactive Case Study Quiz
Comparative Effectiveness of Recombinant Factor VIIa for Off-Label Uses vs. Usual Care in the Hospital Setting
Prepared for:
Agency for Healthcare Research and Quality (AHRQ)
www.ahrq.gov
Comparative Effectiveness of Recombinant Factor VIIa for Off-Label Uses vs.…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/acs-pci-adjunctive-devices_executive.pdf
December 01, 2011 - Layout 1
Background
Coronary stents and adjunctive
pharmacologic agents—including
glycoprotein IIb/IIIa receptor inhibitors and
thienopyridines—have improved the
efficacy of percutaneous coronary
intervention (PCI).1,2 However,
dislodgement of atherothrombotic material
from coronary lesions during PCI can
result in …
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/migraine-prevention_executive.pdf
June 01, 2013 - 1
Comparative Effectiveness Review
Number 108
Migraine in Children:
Preventive Pharmacologic Treatments
Executive Summary
Introduction
The Agency for Healthcare Research
and Quality (AHRQ) commissioned the
Minnesota Evidence-based Practice
Center (EPC) to conduct a review of
preventive pharmacologic treatm…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cystic-fibrosis-hgh_executive.pdf
October 01, 2010 - Layout 1
Background
Cystic fibrosis (CF) is the second most
common life-shortening, childhood-onset
genetic disease in the United States,
affecting approximately 30,000 people in
the Nation. The gene responsible for CF
encodes the cystic fibrosis transmembrane
regulator (CFTR) protein, which regulates
sodium and chl…